MedTrace Logo

NOWOX Oxygen Therapy Monitoring Device

NCT00800072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2014-02-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the duration of oxygen use recorded by the NOWOX, under usual conditions of daily living, in patients with chronic obstructive respiratory disease requiring oxygen therapy.

Conditions

Interventions

DEVICE

NOWOX

one experimental device assigned to each of the 10 patients including in the study for an experiemental session duration of 6 hours

Sponsors & Collaborators

  • Air Liquide SA

    lead INDUSTRY

Principal Investigators

  • Anh-Tuan DINH-XUAN, Professor-MD · Department of Physiology - Cochin University Hospital - FRANCE

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00800072 on ClinicalTrials.gov